We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Treatment of Minor Stroke Radically Reduces Major Stroke Risk

By HospiMedica staff writers
Posted on 19 Dec 2007
A new study has found that rapid assessment and treatment of a first transient ischemic attack (TIA) or minor ischemic stroke reduces risk for subsequent major stroke by about 80%.

Researchers from Bichat-Claude Bernard University Hospital (Paris, France) and Denis Diderot University and Medical School (Paris, France) followed 1,085 patients with suspected TIA between January 2003 and December 2005. More...
The patients were assessed within 4 hours of admission with neurological, arterial, and cardiac imaging. Of these, 574 were seen within 24 hours of symptom onset; 701 had confirmed TIA or minor stroke, and 144 had possible TIA. Of the 643 patients with confirmed TIA, all began a stroke prevention program, with 43 individuals undergoing urgent carotid revascularization and 44 individuals treated for atrial fibrillation with anticoagulants. The study's primary outcome was stroke within 90 days.

At 90 days, the stroke rate was just 1.24%, which compared with an expected rate of 5.96%. According to the authors, this suggests immediate treatment through a dedicated clinic reduced the risk for recurrence of TIA by almost 80%. The study was published in the November 2007 issue of The Lancet Neurology.

"We show prompt evaluation and treatment of patients with TIA in a dedicated outpatient unit is associated with a lower than expected risk of subsequent stroke,” concluded lead author Pierre Amarenco, M.D, from Bichat-Claude Bernard University, and colleagues. "Because almost three-quarters of patients were discharged home on the same day as the diagnosis, the TIA clinic is also likely to involve lower costs and greater patient satisfaction about the management than is treatment without such a clinic.”

The study was conducted in a dedicated hospital clinic running what is known as the SOS-TIA program which provided 24-hour access specifically to assess and treat patients with suspected cerebral or retinal TIAs related to ischemia, and whose symptoms lasted less than 24 hours.


Related Links:
Bichat-Claude Bernard University Hospital
Denis Diderot University and Medical School

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.